Inhibition of hepatitis B virus replication by ligand-mediated activation of RNase L.

Abstract:

:RNase L is a cellular endoribonuclease that is activated by 2',5'-linked oligoadenylates (2-5A), which are unique and specific ligands synthesized by a family of interferon-inducible, dsRNA-activated enzymes named oligoadenylate synthetases. In the typical antiviral pathway, activated RNase L degrades viral and cellular RNAs, thus limiting viral replication and spread. Although the antiviral activity of RNase L has been demonstrated for several RNA viruses, there is little evidence regarding its role against DNA viruses. In the present study, the potential antiviral activity of RNase L against hepatitis B virus (HBV) was explored utilizing the recently reported infection protocol based on human hepatoma HepG2 cells stably complemented with the virus entry factor NTCP. Viral replication and expression in this cell type was markedly inhibited by poly(I:C)- or 2-5A-mediated activation of RNase L; however, the inhibition was significantly reversed by RNase L knockdown. Further analysis in HBV1.2-transfected Huh-7 hepatoma cells indicated that the antiviral activity of RNase L depends on its ribonuclease function. We also provide evidence for the specific roles of OAS family members in this process. These results suggest that HBV replication can be regulated through interferon-mediated RNA decay pathways and that activation of these host antiviral factors may represent a novel therapeutic strategy for HBV infection.

journal_name

Antiviral Res

journal_title

Antiviral research

authors

Park IH,Kwon YC,Ryu WS,Ahn BY

doi

10.1016/j.antiviral.2014.01.021

subject

Has Abstract

pub_date

2014-04-01 00:00:00

pages

118-27

eissn

0166-3542

issn

1872-9096

pii

S0166-3542(14)00033-3

journal_volume

104

pub_type

杂志文章
  • A lumpy skin disease virus deficient of an IL-10 gene homologue provides protective immunity against virulent capripoxvirus challenge in sheep and goats.

    abstract::Sheep and goat pox continue to be important livestock diseases that pose a major threat to the livestock industry in many regions in Africa and Asia. Currently, several live attenuated vaccines are available and used in endemic countries to control these diseases. One of these is a partially attenuated strain of lumpy...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2015.08.016

    authors: Boshra H,Truong T,Nfon C,Bowden TR,Gerdts V,Tikoo S,Babiuk LA,Kara P,Mather A,Wallace DB,Babiuk S

    更新日期:2015-11-01 00:00:00

  • Inhibition of herpes simplex virus in culture by oligonucleotides composed entirely of deoxyguanosine and thymidine.

    abstract::Oligodeoxynucleotides (ODNs) composed entirely of deoxyguanosine and thymidine, but not specifically designed to act as antisense agents, were able to significantly inhibit herpes simplex virus growth in acute infection assay systems. The guanosine/thymidine (GT) ODNs which demonstrated this antiviral activity contain...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(94)00064-f

    authors: Fennewald SM,Mustain S,Ojwang J,Rando RF

    更新日期:1995-01-01 00:00:00

  • Are in vitro hepatitis B core promoter mutations important for clinical alterations in viral load?

    abstract::In vitro studies of HBV core promoter mutations in hepatoma cell lines suggest that some mutations in core promoter transcription factor binding sites result in reduced core promoter activity and viral replication. We sought to validate this hypothesis using clinical samples with viral load differences before and afte...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2005.11.005

    authors: Cheng Y,Seet BL,Ong CS,Wasser S,Tan TM,Peter FJ,Lim SG

    更新日期:2006-03-01 00:00:00

  • Chinese herbal extract Su-duxing had potent inhibitory effects on both wild-type and entecavir-resistant hepatitis B virus (HBV) in vitro and effectively suppressed HBV replication in mouse model.

    abstract::This study aimed to investigate anti-HBV effect and major active compounds of Su-duxing, a medicine extracted from Chinese herbs. HBV-replicating cell lines HepG2.2.15 (wild-type) and HepG2.A64 (entecavir-resistant) were used for in vitro test. C57BL/6 mice infected by adeno-associated virus carrying 1.3 mer wild-type...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2018.04.017

    authors: Liu Y,Yao W,Si L,Hou J,Wang J,Xu Z,Li W,Chen J,Li R,Li P,Bo L,Xiao X,Lan J,Xu D

    更新日期:2018-07-01 00:00:00

  • Antiviral activity of theaflavin digallate against herpes simplex virus type 1.

    abstract::Tea is the second most consumed drink in the world. The beneficial effects of tea have been mostly attributed to its catechin content. Black tea is derived from the leaves of Camellia sinensis plant, and it is rich in theaflavin polyphenols, in particular theaflavin (TF1), theaflavin-3-monogallate (TF2A), theaflavin-3...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2015.03.009

    authors: de Oliveira A,Prince D,Lo CY,Lee LH,Chu TC

    更新日期:2015-06-01 00:00:00

  • Natural product-derived compounds in HIV suppression, remission, and eradication strategies.

    abstract::While combination antiretroviral therapy (cART) has successfully converted HIV to a chronic but manageable infection in many parts of the world, HIV continues to persist within latent cellular reservoirs, which can become reactivated at any time to produce infectious virus. New therapies are therefore needed not only ...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2018.07.016

    authors: Andersen RJ,Ntie-Kang F,Tietjen I

    更新日期:2018-10-01 00:00:00

  • Immunological and biochemical characterizations of coxsackievirus A6 and A10 viral particles.

    abstract::Childhood exanthema caused by different serotypes of coxsackievirus (CV-A) and enterovirus A71 (EV-A71) has become a serious global health problem; it is commonly known as hand, foot, and mouth disease (HFMD). Current EV-A71 vaccine clinical trials have demonstrated that human antibody responses generated by EV-A71 va...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2016.02.008

    authors: Liu CC,Guo MS,Wu SR,Lin HY,Yang YT,Liu WC,Chow YH,Shieh DB,Wang JR,Chong P

    更新日期:2016-05-01 00:00:00

  • An inhibitor of the epidermal growth factor receptor function does not affect the ability of human papillomavirus 11 to form warts in the xenografted immunodeficient mouse model.

    abstract::Epidermal growth factor receptor (EGFr) has been shown to be induced and activated in cells infected with HPV, suggesting that it may play a physiological role in viral replication or in the formation or maintenance of warts. To investigate this possibility, human foreskin tissue was infected with HPV11 and transplant...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2006.12.004

    authors: Parkinson T,Howett MK,Welsh PA,Patrick SD,Neely EB,Flanagan N,Pollack VA,Pustilnik LR,Moyer J,Perros M

    更新日期:2007-04-01 00:00:00

  • Dextran sulfate-resistant A/Puerto Rico/8/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein.

    abstract::Dextran sulfate (DS) is a negatively charged sulfated polysaccharide that suppresses the replication of influenza A viruses. The suppression was thought to be associated with inhibition of the hemagglutinin-dependent fusion activity. However, we previously showed that suppression by DS was observed not only at the ini...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2014.09.002

    authors: Yamada H,Nagao C,Haredy AM,Mori Y,Mizuguchi K,Yamanishi K,Okamoto S

    更新日期:2014-11-01 00:00:00

  • Niclosamide inhibits lytic replication of Epstein-Barr virus by disrupting mTOR activation.

    abstract::Infection with the oncogenic γ-herpesviruses Epstein-Barr virus (EBV) and Kaposi's sarcoma-associated herpesvirus (KSHV) cause several severe malignancies in humans. Inhibition of the lytic replication of EBV and KSHV eliminates the reservoir of persistent infection and transmission, consequently preventing the occurr...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2016.12.002

    authors: Huang L,Yang M,Yuan Y,Li X,Kuang E

    更新日期:2017-02-01 00:00:00

  • In silico study supports the efficacy of a reduced dose regimen for stavudine.

    abstract::Stavudine (d4T) is used extensively as part of HAART in resource poor settings, despite its toxicities. The revised WHO guidelines specify replacement of d4T with less toxic but more expensive drugs when feasible, and that d4T doses be standardized to 30 mg twice daily (bid) (irrespective of body-weight), from the app...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2011.08.004

    authors: Hurwitz SJ,Schinazi RF

    更新日期:2011-11-01 00:00:00

  • Selection and characterization of viruses resistant to the dual acting pyrimidinedione entry and non-nucleoside reverse transcriptase inhibitor IQP-0410.

    abstract::The 1-(2-hydroxyethoxymethyl)-6-(phenylthio)thymine (HEPT)-like compounds with homocyclic moieties at the N-1 of the pyrimidinedione, including the highly potent lead compound IQP-0410, inhibit HIV-1 at sub-nanomolar concentrations primarily through a typical non-nucleoside mechanism involving allosteric inhibition at...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2013.09.005

    authors: Buckheit RW Jr,Watson Buckheit K,Sturdevant CB,Buckheit RW 3rd

    更新日期:2013-11-01 00:00:00

  • Molecular basis of human immunodeficiency virus type 1 drug resistance: overview and recent developments.

    abstract::The introduction of potent combination therapies in the mid-90s had a tremendous effect on AIDS mortality. However, drug resistance has been a major factor contributing to antiretroviral therapy failure. Currently, there are 26 drugs approved for treating human immunodeficiency virus (HIV) infections, although some of...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2013.01.007

    authors: Menéndez-Arias L

    更新日期:2013-04-01 00:00:00

  • Clinical management and infection control of SARS: lessons learned.

    abstract::The outbreak of severe acute respiratory syndrome (SARS) in 2003 was the first emergence of an important human pathogen in the 21st century. Responding to the epidemic provided clinicians with extensive experience in diagnosing and treating a novel respiratory viral disease. In this article, we review the experience o...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2013.08.016

    authors: Cheng VC,Chan JF,To KK,Yuen KY

    更新日期:2013-11-01 00:00:00

  • 3',5'Di-O-trityluridine inhibits in vitro flavivirus replication.

    abstract::The dengue fever virus (DENV) and the yellow fever virus (YFV) are members of the genus flavivirus in the family Flaviviridae. An estimated 50-100 million cases of DENV infections occur each year and approximately half a million patients require hospitalization. There is no vaccine or effective antiviral treatment ava...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2013.01.011

    authors: De Burghgraeve T,Selisko B,Kaptein S,Chatelain G,Leyssen P,Debing Y,Jacobs M,Van Aerschot A,Canard B,Neyts J

    更新日期:2013-05-01 00:00:00

  • Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon.

    abstract::Interleukin (IL)28-B polymorphism has been related to interferon response in the treatment of hepatitis C, but its role in chronic hepatitis B (CHB) therapy is still poorly understood. We aimed to investigate the effect of IL28-B polymorphisms in the treatment with pegylated-interferon (PEG-IFN) of patients with CHB. ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2013.11.014

    authors: Boglione L,Cusato J,Allegra S,Esposito I,Patti F,Cariti G,Di Perri G,D'Avolio A

    更新日期:2014-02-01 00:00:00

  • Highly potent and selective inhibition of bovine viral diarrhea virus replication by γ-carboline derivatives.

    abstract::Several novel γ-carboline derivatives were identified as selective inhibitors of bovine viral diarrhea virus (BVDV) replication in cell cultures. Among them, 3,4,5-trimethyl-γ-carboline (SK3M4M5M) was the most active against BVDV (Nose strain) in MDBK cells, with a 50% effective concentration of 0.017±0.005μM and a se...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2010.09.013

    authors: Salim MT,Goto Y,Hamasaki T,Okamoto M,Aoyama H,Hashimoto Y,Musiu S,Paeshuyse J,Neyts J,Froeyen M,Herdewijn P,Baba M

    更新日期:2010-12-01 00:00:00

  • Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.

    abstract:BACKGROUND:Lactoferrin (LF) is a glycoprotein present in human milk with known antimicrobial effects. In vitro, LF has demonstrated antiviral activity against respiratory syncytial virus (RSV). We sought to assess the effect of bovine (b)LF in RSV replication, lung inflammation and function, cytokine profiles and clini...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2013.05.013

    authors: Gualdi L,Mertz S,Gomez AM,Ramilo O,Wittke A,Mejias A

    更新日期:2013-08-01 00:00:00

  • Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents.

    abstract::Infection of captive macaques with simian immunodeficiency virus (SIV) and domestic cats with feline immunodeficiency virus (FIV), both discovered in the last five years, represent excellent animal models for infection of humans with the human immunodeficiency virus (HIV). Protection against challenge infection and pr...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/0166-3542(91)90009-g

    authors: Gardner MB

    更新日期:1991-05-01 00:00:00

  • Maraviroc Clinical Test (MCT) as an alternative tool to decide CCR5-antagonists prescription in naïve HIV-infected patients.

    abstract::Our aim was to analyze the virological response to a combined antiretroviral therapy started after Maraviroc Clinical Test (MCT) in naïve HIV-infected patients. Forty-one patients were exposed to MCT, based on an 8-day MVC monotherapy. If undetectability or a viral load reduction >1 log10 HIV-RNA copies/ml was achieve...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2015.06.018

    authors: Genebat M,de Pablo-Bernal RS,Pulido I,Jiménez-Mejías ME,Martínez O,Pacheco YM,Raffi-El-Idrissi Benhia M,Abad MA,Ruiz-Mateos E,Leal M

    更新日期:2015-09-01 00:00:00

  • Protein kinases C as potential host targets for the inhibition of chikungunya virus replication.

    abstract::We have shown previously that prostratin, a non-tumor promoting phorbol ester, inhibits chikungunya virus (CHIKV)-induced cytopathic effects in vitro. Prostratin is a potent activator of protein kinases C (PKC), a family of related serine/threonine kinases that regulate many cellular processes such as proliferation an...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2016.12.020

    authors: Abdelnabi R,Amrun SN,Ng LF,Leyssen P,Neyts J,Delang L

    更新日期:2017-03-01 00:00:00

  • Comparative therapeutic effect of aerosolized and oral rimantadine HCl in experimental human influenza A virus infection.

    abstract::Thirty-six adult volunteers were inoculated intranasally with 7.2 log10 egg infectious doses 50% of an attenuated A/Khabarovsk/77/H1N1 virus. Twenty-four hours later volunteers were begun on both aerosol treatments (rimantadine HCl 25 mg in saline or saline, 10 min exposure twice daily) and oral medications (rimantadi...

    journal_title:Antiviral research

    pub_type: 临床试验,杂志文章

    doi:10.1016/0166-3542(82)90016-x

    authors: Hayden FG,Zylidnikov DM,Iljenko VI,Padolka YV

    更新日期:1982-08-01 00:00:00

  • Anti-HIV (human immunodeficiency virus) activity of sulfated paramylon.

    abstract::Sulfated derivatives of paramylon, a water-insoluble (1-3)-beta-D-glucan from Euglena gracilis, significantly inhibited the cytopathic effect of human immunodeficiency virus (HIV-1, HIV-2) and the expression of HIV antigen in cultured MT-4, MOLT-4 cells and human peripheral blood mononuclear cells. Native paramylon, N...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/0166-3542(93)90063-o

    authors: Koizumi N,Sakagami H,Utsumi A,Fujinaga S,Takeda M,Asano K,Sugawara I,Ichikawa S,Kondo H,Mori S

    更新日期:1993-05-01 00:00:00

  • Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance.

    abstract::Oxymatrine (OMTR) is an anti-hepatitis drug used in China. Its mechanism of action is unknown. Recently, we found that OMTR inhibits hepatitis B virus (HBV) via down-regulating the expression of heat-stress cognate 70 (Hsc70), a host protein required for HBV DNA replication. Goal of this study was to assess the effect...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2011.01.005

    authors: Wang YP,Zhao W,Xue R,Zhou ZX,Liu F,Han YX,Ren G,Peng ZG,Cen S,Chen HS,Li YH,Jiang JD

    更新日期:2011-03-01 00:00:00

  • High-throughput screening for negative-stranded hemorrhagic fever viruses using reverse genetics.

    abstract::Viral hemorrhagic fevers (VHFs) cause thousands of fatalities every year, but the treatment options for their management remain very limited. In particular, the development of therapeutic interventions is restricted by the lack of commercial viability of drugs targeting individual VHF agents. This makes approaches lik...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2019.104569

    authors: Wendt L,Bostedt L,Hoenen T,Groseth A

    更新日期:2019-10-01 00:00:00

  • Heparin octasaccharide decoy liposomes inhibit replication of multiple viruses.

    abstract::Heparan sulfate (HS) is a ubiquitous glycosaminoglycan that serves as a cellular attachment site for a number of significant human pathogens, including respiratory syncytial virus (RSV), human parainfluenza virus 3 (hPIV3), and herpes simplex virus (HSV). Decoy receptors can target pathogens by binding to the receptor...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2015.01.008

    authors: Hendricks GL,Velazquez L,Pham S,Qaisar N,Delaney JC,Viswanathan K,Albers L,Comolli JC,Shriver Z,Knipe DM,Kurt-Jones EA,Fygenson DK,Trevejo JM,Wang JP,Finberg RW

    更新日期:2015-04-01 00:00:00

  • Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin.

    abstract::Infection by one of the 4 distinct serotypes of dengue virus (DENV) threatens >40% of the world's population, with no efficacious vaccine or antiviral agent currently available. DENV replication through the virus-encoded nonstructural protein (NS) 5 protein occurs in the infected cell cytoplasm, but NS5 from DENV2 has...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2013.06.002

    authors: Tay MY,Fraser JE,Chan WK,Moreland NJ,Rathore AP,Wang C,Vasudevan SG,Jans DA

    更新日期:2013-09-01 00:00:00

  • A dual chicken IgY against rotavirus and norovirus.

    abstract::Rotavirus (RV) and norovirus (NoV) are the two most important causes of viral gastroenteritis. While vaccine remains an effective prophylactic strategy, development of other approaches, such as passive immunization to control and treat clinical infection and illness of these two pathogens, is necessary. Previously we ...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2012.12.011

    authors: Dai YC,Zhang XF,Tan M,Huang P,Lei W,Fang H,Zhong W,Jiang X

    更新日期:2013-03-01 00:00:00

  • Therapeutic vaccination against chronic hepatitis C virus infection.

    abstract::Approximately 170 million people worldwide are chronic carriers of Hepatitis C virus (HCV). To date, there is no prophylactic vaccine available against HCV. The standard-of-care therapy for HCV infection involves a combination of pegylated interferon-α and ribavirin. This therapy, which is commonly associated with sid...

    journal_title:Antiviral research

    pub_type: 杂志文章,评审

    doi:10.1016/j.antiviral.2012.07.006

    authors: Ip PP,Nijman HW,Wilschut J,Daemen T

    更新日期:2012-10-01 00:00:00

  • Full protection of swine against foot-and-mouth disease by a bivalent B-cell epitope dendrimer peptide.

    abstract::Foot-and-mouth disease virus (FMDV) causes a highly contagious disease of cloven-hoofed animals. We have reported (Cubillos et al., 2008) that a synthetic dendrimeric peptide consisting of four copies of a B-cell epitope [VP1(136-154)] linked through thioether bonds to a T-cell epitope [3A(21-35)] of FMDV [B4T(thi)] e...

    journal_title:Antiviral research

    pub_type: 杂志文章

    doi:10.1016/j.antiviral.2016.03.005

    authors: Blanco E,Guerra B,de la Torre BG,Defaus S,Dekker A,Andreu D,Sobrino F

    更新日期:2016-05-01 00:00:00